Showing results (1-10 of 469) with videos related to
Sort By:
Pageof 47
Cancer Chemotherapy and Pharmacology|January 1, 1985
Comparative cytotoxicities of various morpholinyl anthracyclinesD G Streeter, D L Taylor, E M Acton, et al.Journal of Medicinal Chemistry|October 1, 1986
N-(cyanomethyl)- and N-(2-methoxy-1-cyanoethyl)anthracyclines and related carboxyl derivativesE M Acton, G L Tong, D L Taylor, et al.Journal of Medicinal Chemistry|October 1, 1986
N-(2-hydroxyethyl)doxorubicin from hydrolysis of 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicinE M Acton, G L Tong, T H Smith, et al.Journal of Cardiovascular Pharmacology|January 1, 1984
Doxorubicin cardiotoxicity in the rat: comparison of electrocardiogram, transmembrane potential, and structural effectsR A Jensen, E M Acton, J H PetersCancer Research|September 1, 1984
Electrocardiographic and transmembrane potential effects of 5-iminodaunorubicin in the ratR A Jensen, E M Acton, J H PetersCancer Chemotherapy and Pharmacology|January 1, 1986
Uptake and retention of morpholinyl anthracyclines by adriamycin-sensitive and -resistant P388 cellsD G Streeter, J S Johl, G R Gordon, et al.Cancer Research|April 1, 1984
Metabolic disposition of 5-iminodaunorubicin in the ratJ H Peters, G R Gordon, D Kashiwase, et al.Cancer Chemotherapy and Pharmacology|January 1, 1981
Tissue distribution of doxorubicin and doxorubicinol in rats receiving multiple doses of doxorubicinJ H Peters, G R Gordon, D Kashiwase, et al.Cancer Chemotherapy and Pharmacology|January 1, 1980
Effects of 5-iminodaunorubicin on nucleoli of ratsJ H Peters, M J Evans, R A Jensen, et al.Anticancer Research|November 1, 1987
Comparative redox activities of anthracyclines by microsomes from P388 cells and rat liverJ H Peters, D G Streeter, J S Johl, et al.Pageof 47